Similar articles

• Dose administration of gadolinium-DTPA in MR imaging of intracranial tumors.

  Niendorf HP, Laniado M, Semmler W, Schörner W, Felix R. Niendorf HP, et al. AJNR Am J Neuroradiol. 1987 Sep-Oct;8(5):803-15. AJNR Am J Neuroradiol. 1987. PMID: 2823588 Free PMC article.
• Contrast enhancement of brain tumors at different MR field strengths: comparison of 0.5 T and 2.0 T.

  Chang KH, Ra DG, Han MH, Cha SH, Kim HD, Han MC. Chang KH, et al. AJNR Am J Neuroradiol. 1994 Sep;15(8):1413-9; discussion 1420-3. AJNR Am J Neuroradiol. 1994. PMID: 7985558 Free PMC article.
• Spin-lock imaging in contrast-enhanced magnetic resonance imaging of human gliomas.

  Aronen HJ, Peltonen TK, Tanttu JI, Sipilä LM, Ruhala MT, Jääskeläinen J, Sepponen R. Aronen HJ, et al. Acad Radiol. 1996 Aug;3 Suppl 2:S170-2. doi: 10.1016/s1076-6332(96)80524-1. Acad Radiol. 1996. PMID: 8796553 No abstract available.
• The application of contrast agents in the evaluation of neoplasms of the central nervous system.

  Yuh WT, Fisher DJ, Nguyen HD, Tali ET, Mayr NA. Yuh WT, et al. Top Magn Reson Imaging. 1992 Sep;4(4):1-6. Top Magn Reson Imaging. 1992. PMID: 1419031 Review.
• [Artificial contrasting during magnetic resonance tomography].

  Sergeev PV, Panov OV, Egorova SV, Bolotova EN, Shimanovskii NL, Akhadov TA, Sviridov NK. Sergeev PV, et al. Vestn Rentgenol Radiol. 1997 Jan-Feb;(1):45-52. Vestn Rentgenol Radiol. 1997. PMID: 9133071 Review. Russian. No abstract available.